Aegis against stroke and dementia by angiotensin type 1 receptor blockers: new beneficial aspects.
Morishita
Ryuichi
R
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000809:Angiotensins / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000473:pathology; D002545:Brain Ischemia / Q000188:drug therapy; D003704:Dementia / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000473:pathology; D051379:Mice; D018696:Neuroprotective Agents; D012084:Renin-Angiotensin System / Q000502:physiology; D020521:Stroke / Q000473:pathology / Q000517:prevention & control*
D047228:Angiotensin II Type 1 Receptor Blockers; D000809:Angiotensins; D018696:Neuroprotective Agents